Patents by Inventor Kurt Swanson

Kurt Swanson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Ferritin proteins
    Patent number: 11904009
    Abstract: Ferritin proteins comprising a mutation replacing a surface-exposed amino acid with a cysteine, an N- or C-terminal linker comprising a cysteine, and/or one or more immune-stimulatory moieties linked to the ferritin protein via a surface-exposed amino acid are disclosed. The ferritin proteins can further comprise a non-ferritin polypeptide and be antigenic, e.g., for use in eliciting antibodies against the non-ferritin polypeptide.
    Type: Grant
    Filed: October 1, 2020
    Date of Patent: February 20, 2024
    Assignee: SANOFI
    Inventors: Gary J. Nabel, Chih-Jen Wei, Kurt Swanson
  • ANTIGENIC EPSTEIN BARR VIRUS POLYPEPTIDES
    Publication number: 20240050518
    Abstract: This disclosure relates to antigenic EBV polypeptides and their use in eliciting antibodies against EBV. Also disclosed are antigenic polypeptides comprising an EBV polypeptide and a ferritin protein.
    Type: Application
    Filed: June 15, 2023
    Publication date: February 15, 2024
    Applicant: SANOFI
    Inventors: Gary J. Nabel, Chih-Jen Wei, Laura Nguyen, Kurt Swanson, Te-Hui Chou, Stefan Koester
  • RSV F PROTEIN COMPOSITIONS AND METHODS FOR MAKING SAME
    Publication number: 20240034773
    Abstract: The present invention relates to immunogenic compositions comprising RSV F protein, methods for preparing compositions that contain RSV F protein ecto-domain polypeptides, and to certain engineered RSV F proteins and nucleic acids that encode the engineered RSV F proteins. Compositions prepared using the methods can contain RSV F protein ecto-domain polypeptides in a predominant or single desired form and conformation. The invention also relates to methods for inducing an immune response to RSV F.
    Type: Application
    Filed: May 24, 2023
    Publication date: February 1, 2024
    Inventors: Kurt SWANSON, Philip R. DORMITZER
  • SYSTEMS AND METHODS FOR GENERATING FULFILLMENT INTERFACES INCLUDING AUTOMATIC FULFILLMENT DETERMINATION
    Publication number: 20230401622
    Abstract: Systems and methods of generating a fulfillment interface are disclosed. A request for a fulfillment interface is received from a first device. The request identifies a plurality of items for an order. Fulfillment options are determined for each of the items and a first fulfillment plan including a first fulfillment option for a first set of items and a second fulfillment option for a second set of items is generated. The first and second fulfillment options are generated based on the fulfillment options of the corresponding set of items and a customer intent. The fulfillment interface including the first fulfillment plan is generated and transmitted to the first device for display. The interface includes a first portion identifying the first fulfillment option and each of the first set of items and a second portion identifying the second fulfillment option and each of the second set of items.
    Type: Application
    Filed: June 7, 2023
    Publication date: December 14, 2023
    Inventors: Siddharth Rao, Sony Mangalassery Gregory, Mangala Mathe, Kannan Chellappa, Eric Nelson Elem, Mengzeng Rao, Sriram Uppuluri, Kurt Swanson, Keshav Agrawal, Arpit Agrawal, Anilkumar Garikepati, Balaji Sangabattuni, Justin Jose
  • RSV F protein compositions and methods for making same
    Patent number: 11827694
    Abstract: The present invention relates to immunogenic compositions comprising RSV F protein, methods for preparing compositions that contain RSV F protein ecto-domain polypeptides, and to certain engineered RSV F proteins and nucleic acids that encode the engineered RSV F proteins. Compositions prepared using the methods can contain RSV F protein ecto-domain polypeptides in a predominant or single desired form and conformation. The invention also relates to methods for inducing an immune response to RSV F.
    Type: Grant
    Filed: February 22, 2023
    Date of Patent: November 28, 2023
    Assignee: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventors: Kurt Swanson, Philip R. Dormitzer
  • RSV F protein compositions and methods for making same
    Patent number: 11820812
    Abstract: The present invention relates to immunogenic compositions comprising RSV F protein, methods for preparing compositions that contain RSV F protein ecto-domain polypeptides, and to certain engineered RSV F proteins and nucleic acids that encode the engineered RSV F proteins. Compositions prepared using the methods can contain RSV F protein ecto-domain polypeptides in a predominant or single desired form and conformation. The invention also relates to methods for inducing an immune response to RSV F.
    Type: Grant
    Filed: December 29, 2021
    Date of Patent: November 21, 2023
    Assignee: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventors: Kurt Swanson, Philip R. Dormitzer
  • RSV F PROTEIN COMPOSITIONS AND METHODS FOR MAKING SAME
    Publication number: 20230357369
    Abstract: The present invention relates to immunogenic compositions comprising RSV F protein, methods for preparing compositions that contain RSV F protein ecto-domain polypeptides, and to certain engineered RSV F proteins and nucleic acids that encode the engineered RSV F proteins. Compositions prepared using the methods can contain RSV F protein ecto-domain polypeptides in a predominant or single desired form and conformation. The invention also relates to methods for inducing an immune response to RSV F.
    Type: Application
    Filed: May 24, 2023
    Publication date: November 9, 2023
    Inventors: Kurt SWANSON, Philip R. DORMITZER
  • RSV F PROTEIN COMPOSITIONS AND METHODS FOR MAKING SAME
    Publication number: 20230357371
    Abstract: The present invention relates to immunogenic compositions comprising RSV F protein, methods for preparing compositions that contain RSV F protein ecto-domain polypeptides, and to certain engineered RSV F proteins and nucleic acids that encode the engineered RSV F proteins. Compositions prepared using the methods can contain RSV F protein ecto-domain polypeptides in a predominant or single desired form and conformation. The invention also relates to methods for inducing an immune response to RSV F.
    Type: Application
    Filed: May 24, 2023
    Publication date: November 9, 2023
    Inventors: Kurt SWANSON, Philip R. DORMITZER
  • RSV F PROTEIN COMPOSITIONS AND METHODS FOR MAKING SAME
    Publication number: 20230357370
    Abstract: The present invention relates to immunogenic compositions comprising RSV F protein, methods for preparing compositions that contain RSV F protein ecto-domain polypeptides, and to certain engineered RSV F proteins and nucleic acids that encode the engineered RSV F proteins. Compositions prepared using the methods can contain RSV F protein ecto-domain polypeptides in a predominant or single desired form and conformation. The invention also relates to methods for inducing an immune response to RSV F.
    Type: Application
    Filed: May 24, 2023
    Publication date: November 9, 2023
    Inventors: Kurt SWANSON, Philip R. DORMITZER
  • RSV F PROTEIN COMPOSITIONS AND METHODS FOR MAKING SAME
    Publication number: 20230348575
    Abstract: The present invention relates to immunogenic compositions comprising RSV F protein, methods for preparing compositions that contain RSV F protein ecto-domain polypeptides, and to certain engineered RSV F proteins and nucleic acids that encode the engineered RSV F proteins. Compositions prepared using the methods can contain RSV F protein ecto-domain polypeptides in a predominant or single desired form and conformation. The invention also relates to methods for inducing an immune response to RSV F.
    Type: Application
    Filed: May 24, 2023
    Publication date: November 2, 2023
    Inventors: Kurt SWANSON, Philip R. DORMITZER
  • RSV F PROTEIN COMPOSITIONS AND METHODS FOR MAKING SAME
    Publication number: 20230348574
    Abstract: The present invention relates to immunogenic compositions comprising RSV F protein, methods for preparing compositions that contain RSV F protein ecto-domain polypeptides, and to certain engineered RSV F proteins and nucleic acids that encode the engineered RSV F proteins. Compositions prepared using the methods can contain RSV F protein ecto-domain polypeptides in a predominant or single desired form and conformation. The invention also relates to methods for inducing an immune response to RSV F.
    Type: Application
    Filed: February 22, 2023
    Publication date: November 2, 2023
    Inventors: Kurt SWANSON, Philip R. DORMITZER
  • RSV F PROTEIN COMPOSITIONS AND METHODS FOR MAKING SAME
    Publication number: 20230303669
    Abstract: The present invention relates to immunogenic compositions comprising RSV F protein, methods for preparing compositions that contain RSV F protein ecto-domain polypeptides, and to certain engineered RSV F proteins and nucleic acids that encode the engineered RSV F proteins. Compositions prepared using the methods can contain RSV F protein ecto-domain polypeptides in a predominant or single desired form and conformation. The invention also relates to methods for inducing an immune response to RSV F.
    Type: Application
    Filed: May 24, 2023
    Publication date: September 28, 2023
    Inventors: Kurt SWANSON, Philip R. DORMITZER
  • PRE-FUSION RSV F ANTIGENS
    Publication number: 20230287056
    Abstract: The invention relates to pre-fusion RSV F protein and polypeptides that contain one or more amino acid mutations that stabilize the pre-fusion conformation or destabilize the post-fusion conformation. The invention also relates to methods for inducing an immune response to pre-fusion RSV F.
    Type: Application
    Filed: April 27, 2023
    Publication date: September 14, 2023
    Inventors: Kurt SWANSON, Andrea CARFI
  • ANTIGENIC EPSTEIN BARR VIRUS POLYPEPTIDES
    Publication number: 20230277619
    Abstract: This disclosure relates to antigenic EBV polypeptides and their use in eliciting antibodies against EBV. Also disclosed are antigenic polypeptides comprising an EBV polypeptide and a ferritin protein.
    Type: Application
    Filed: December 19, 2022
    Publication date: September 7, 2023
    Applicant: SANOFI
    Inventors: Gary J. Nabel, Chih-Jen Wei, Laura Nguyen, Kurt Swanson, Te-Hui Chou, Stefan Koester
  • RSV F protein compositions and methods for making same
    Patent number: 11655284
    Abstract: The present invention relates to immunogenic compositions comprising RSV F protein, methods for preparing compositions that contain RSV F protein ecto-domain polypeptides, and to certain engineered RSV F proteins and nucleic acids that encode the engineered RSV F proteins. Compositions prepared using the methods can contain RSV F protein ecto-domain polypeptides in a predominant or single desired form and conformation. The invention also relates to methods for inducing an immune response to RSV F.
    Type: Grant
    Filed: June 23, 2022
    Date of Patent: May 23, 2023
    Assignee: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventors: Kurt Swanson, Philip R. Dormitzer
  • RSV F protein compositions and methods for making same
    Patent number: 11629181
    Abstract: The present invention relates to immunogenic compositions comprising RSV F protein, methods for preparing compositions that contain RSV F protein ecto-domain polypeptides, and to certain engineered RSV F proteins and nucleic acids that encode the engineered RSV F proteins. Compositions prepared using the methods can contain RSV F protein ecto-domain polypeptides in a predominant or single desired form and conformation. The invention also relates to methods for inducing an immune response to RSV F.
    Type: Grant
    Filed: June 23, 2022
    Date of Patent: April 18, 2023
    Assignee: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventors: Kurt Swanson, Philip R. Dormitzer
  • Antigenic Epstein Barr virus polypeptides
    Patent number: 11617780
    Abstract: This disclosure relates to antigenic EBV polypeptides and their use in eliciting antibodies against EBV. Also disclosed are antigenic polypeptides comprising an EBV polypeptide and a ferritin protein.
    Type: Grant
    Filed: October 1, 2020
    Date of Patent: April 4, 2023
    Assignee: SANOFI
    Inventors: Gary J. Nabel, Chih-Jen Wei, Laura Nguyen, Kurt Swanson, Te-Hui Chou, Stefan Koester
  • RSV F PROTEIN COMPOSITIONS AND METHODS FOR MAKING SAME
    Publication number: 20220372115
    Abstract: The present invention relates to immunogenic compositions comprising RSV F protein, methods for preparing compositions that contain RSV F protein ecto-domain polypeptides, and to certain engineered RSV F proteins and nucleic acids that encode the engineered RSV F proteins. Compositions prepared using the methods can contain RSV F protein ecto-domain polypeptides in a predominant or single desired form and conformation. The invention also relates to methods for inducing an immune response to RSV F.
    Type: Application
    Filed: June 23, 2022
    Publication date: November 24, 2022
    Applicant: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventors: Kurt SWANSON, Philip R. DORMITZER
  • RSV F PROTEIN COMPOSITIONS AND METHODS FOR MAKING SAME
    Publication number: 20220340645
    Abstract: The present invention relates to immunogenic compositions comprising RSV F protein, methods for preparing compositions that contain RSV F protein ecto-domain polypeptides, and to certain engineered RSV F proteins and nucleic acids that encode the engineered RSV F proteins. Compositions prepared using the methods can contain RSV F protein ecto-domain polypeptides in a predominant or single desired form and conformation. The invention also relates to methods for inducing an immune response to RSV F.
    Type: Application
    Filed: June 23, 2022
    Publication date: October 27, 2022
    Applicant: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventors: Kurt SWANSON, Philip R. DORMITZER
  • PRE-FUSION RSV F ANTIGENS
    Publication number: 20220332766
    Abstract: The invention relates to pre-fusion RSV F protein and polypeptides that contain one or more amino acid mutations that stabilize the pre-fusion conformation or destabilize the post-fusion conformation. The invention also relates to methods for inducing an immune response to pre-fusion RSV F.
    Type: Application
    Filed: June 23, 2022
    Publication date: October 20, 2022
    Applicant: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventors: Kurt SWANSON, Andrea CARFI